Artificial Neural Networks and Gene Filtering Distinguish Between Global Gene Expression Profiles of Barrett ’ s Esophagus and Esophageal Cancer 1

cDNA microarrays, combined with bioinformatics analyses, are becoming increasingly used in current medical research. Existing analytic methods, particularly those that are unsupervised, often have difficulty recognizing subtle differences among predefined subgroups. In contrast, supervised methods, such as Artificial Neural Networks (ANNs), are able to recognize subtly different biological entities. We applied ANNs in a proof-of-principle study of cDNA microarray data in esophageal cancer (CA) and premalignancy. cDNA microarrays, each containing 8064 clones, were hybridized to RNAs from 22 esophageal lesions, including 14 Barrett’s esophagus (BA) metaplasias and 8 esophageal carcinomas (3 squamous cell carcinomas and 5 adenocarcinomas). Scanned cDNA microarray data were analyzed using the bioinformatics software Cluster/ TreeView, Significance Analysis of Microarrays (SAM), and ANNs. Cluster analysis based on all 8064 clones on the microarrays was unable to correctly distinguish BA specimens from CA specimens. SAM then selected 160 differentially expressed genes between Barrett’s and cancer. Cluster analysis based on this reduced set still misclassified 2 Barrett’s as cancers. The ANN was trained on 12 samples and tested against the remaining 10 samples. Using the 160 selected genes, the ANN correctly diagnosed all 10 samples in the test set. Finally, the 160 genes selected by SAM may merit further study as biomarkers of neoplastic progression in the esophagus, as well as in elucidating pathological mechanisms underlying BA and CA.

[1]  Noam Harpaz,et al.  Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. , 2002, Gastroenterology.

[2]  D. Shibata,et al.  Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays , 2002, Oncogene.

[3]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[4]  J. Welsh,et al.  Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. , 2001, Cancer research.

[5]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[6]  Christine Brun,et al.  In silico prediction of protein-protein interactions in human macrophages , 2001, BMC Research Notes.

[7]  P. Snow,et al.  Introduction to artificial neural networks for physicians: Taking the lid off the black box , 2001, The Prostate.

[8]  O. Kallioniemi,et al.  Novel findings in gene expression detected in human osteosarcoma by cDNA microarray. , 2000, Cancer genetics and cytogenetics.

[9]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[10]  Z. Gamliel Incidence, epidemiology, and etiology of esophageal cancer. , 2000, Chest surgery clinics of North America.

[11]  Hans A. Kestler,et al.  Classification of spatial textures in benign and cancerous glandular tissues by stereology and stochastic geometry using artificial neural networks , 2000, Journal of microscopy.

[12]  Cheryl Schmidt,et al.  Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis , 2000, Oncogene.

[13]  S. Reed,et al.  Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. , 2000, Cancer research.

[14]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[15]  Blot Wj,et al.  The changing epidemiology of esophageal cancer. , 1999, Seminars in oncology.

[16]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G Gacci,et al.  Predicting ovarian malignancy: application of artificial neural networks to transvaginal and color Doppler flow US. , 1999, Radiology.

[18]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Michael Ruogu Zhang,et al.  Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. , 1998, Molecular biology of the cell.

[20]  M. Bittner,et al.  Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. , 1998, Cancer research.

[21]  David Botstein,et al.  Probing Lymphocyte Biology by Genomic-Scale Gene Expression Analysis , 1998, Journal of Clinical Immunology.

[22]  D. Botstein,et al.  The transcriptional program of sporulation in budding yeast. , 1998, Science.

[23]  L. Bottaci,et al.  Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions , 1997, The Lancet.

[24]  N. Altorki,et al.  Epidemiology and molecular biology of Barrett's adenocarcinoma. , 1997, Seminars in surgical oncology.

[25]  L. Karnell,et al.  National Cancer Data Base report on esophageal carcinoma , 1996, Cancer.

[26]  L. Liotta,et al.  Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. , 1996, Cancer research.

[27]  P. Pairolero,et al.  Barrett's disease: pathophysiology of metaplasia and adenocarcinoma. , 1993, The Annals of thoracic surgery.

[28]  J. Eberwine,et al.  Amplified RNA synthesized from limited quantities of heterogeneous cDNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[30]  S. Hamilton,et al.  Adenocarcinoma of the lower esophagus. A disease primarily of white men with Barrett's esophagus. , 1986, Journal of clinical gastroenterology.

[31]  H. B. Gregorie,et al.  CARCINOMA OF THE ESOPHAGUS , 1952, Annals of surgery.

[32]  R. Narayanan,et al.  Microarray-based expression profiling in prostate tumors. , 2000, In vivo.

[33]  J. Jankowski,et al.  Genetic versus environmental interactions in the oesophagitis-metaplasia-dysplasia-adenocarcinoma sequence (MCS) of Barrett's oesophagus. , 2000, Acta gastro-enterologica Belgica.

[34]  S. Kehoe,et al.  Artificial neural networks and survival prediction in ovarian carcinoma. , 2000, European journal of gynaecological oncology.

[35]  P. Brown,et al.  DNA arrays for analysis of gene expression. , 1999, Methods in enzymology.

[36]  D. Botstein,et al.  The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.

[37]  M. Jackson,et al.  Gene expression profiles of laser-captured adjacent neuronal subtypes , 1999, Nature Medicine.